Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 765-772, February 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, W. G.
Right arrow Articles by Palade, G. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Roberts, W. G.
Right arrow Articles by Palade, G. E.

Neovasculature Induced by Vascular Endothelial Growth Factor Is Fenestrated1

W. Gregory Roberts2 and George E. Palade

Cellular and Molecular Medicine, University of California-San Diego, La Jolla, California 92093-0651

We have reported previously that topical administration of vascular endothelial growth factor165 (VEGF) to a microvascular bed supplied with a continuous endothelium can rapidly induce the formation of endothelial fenestrations (W. G. Roberts and G. E. Palade, J. Cell Sci., 108: 2369–2379, 1995). From these results, we hypothesized that tumor vasculature, in general, may also be fenestrated because it has been reported that tumor secretion of VEGF causes the surrounding host vasculature to invade and feed the growing tumor. Using electron microscopy to characterize the endothelial cell morphology in tumor vessels from either the periphery or the core of the tumor and immunoblotting to detect secreted VEGF, we analyzed the vasculature of human and murine neoplastic tumors grown s.c. in male nude mice. To clarify the role of VEGF165, two models were used: (a) Chinese hamster ovary (CHO) cells stably transfected with hu VEGF165 and injected into mice (VEGF:CHO tumors); and (b) slow-release pellets containing purified VEGF or basic fibroblast growth factor implanted on the rat cremaster muscle. All tumors had vessels with fenestrated endothelium, open interendothelial junctions, and clustered fused caveolae. From all of the peripheral tumor vessels observed, fenestrated endothelium was observed in 41% from EMT, 35% from M1S, 37% from U87, and 56% from VEGF:CHO tumors, whereas surrounding skin and muscle, from which tumor vessels were derived, had fenestrated endothelium in 2 and 0% of all vessels, respectively. Additionally, further analysis revealed a substantial decrease in the anionic glycocalyx on the luminal face of the fenestral diaphragms in endothelium from tumors (especially VEGF:CHO) when compared to intestine or pancreas. Because the host tissue microvascular endothelium which supplies the tumor is not fenestrated, tumors can transform nonproliferating, nonfenestrated vessels into proliferating vessels, many of which have fenestrated endothelium. These data provide evidence that chronic VEGF exposure can induce fenestrations in nonfenestrated endothelium similar to the fenestrated endothelium found in tumor vessels.

1 This study was supported by National Heart, Lung, and Blood Institute Grant HL-17080.

2 To whom requests for reprints should be addressed, at Cellular and Molecular Medicine-0651, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0651. Phone: (619) 534-7712; Fax: (619) 534-8549.

Received 7/15/96. Accepted 12/20/96.




This article has been cited by other articles:


Home page
FASEB J.Home page
Y. Qiu, H. Bevan, S. Weeraperuma, D. Wratting, D. Murphy, C. R Neal, D. O. Bates, and S. J. Harper
Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b
FASEB J, April 1, 2008; 22(4): 1104 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. E. Jaalouk, M. G. Ozawa, J. Sun, J. Lahdenranta, R. O. Schlingemann, R. Pasqualini, and W. Arap
The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor Binding Site within Neuropilin-1
Cancer Res., October 15, 2007; 67(20): 9623 - 9629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. H. Chidlow Jr., D. Shukla, M. B. Grisham, and C. G. Kevil
Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G5 - G18.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. R. Langley and I. J. Fidler
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Endocr. Rev., May 1, 2007; 28(3): 297 - 321.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. W.M NG and A. P ADAMIS
Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
Ann. N.Y. Acad. Sci., October 1, 2006; 1082(1): 151 - 171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Guan, G. Villegas, J. Teichman, P. Mundel, and A. Tufro
Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F422 - F428.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Chen, B. W. Pogue, J. M. Luna, R. L. Hardman, P. J. Hoopes, and T. Hasan
Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications
Clin. Cancer Res., February 1, 2006; 12(3): 917 - 923.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Criscuoli, M. Nguyen, and B. P. Eliceiri
Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability
Blood, February 15, 2005; 105(4): 1508 - 1514.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Nakamura and T. Niwa
Pyridoxal Phosphate and Hepatocyte Growth Factor Prevent Dialysate-Induced Peritoneal Damage
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G KRIKUN, F SCHATZ, and C J LOCKWOOD
Endometrial Angiogenesis: From Physiology to Pathology
Ann. N.Y. Acad. Sci., December 1, 2004; 1034(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Baluk, C. G. Lee, H. Link, E. Ator, A. Haskell, J. A. Elias, and D. M. McDonald
Regulated Angiogenesis and Vascular Regression in Mice Overexpressing Vascular Endothelial Growth Factor in Airways
Am. J. Pathol., October 1, 2004; 165(4): 1071 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. L. Madden, B. P. Cook, M. Nacht, W. D. Weber, M. R. Callahan, Y. Jiang, M. R. Dufault, X. Zhang, W. Zhang, J. Walter-Yohrling, et al.
Vascular Gene Expression in Nonneoplastic and Malignant Brain
Am. J. Pathol., August 1, 2004; 165(2): 601 - 608.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. V. Stan, E. Tkachenko, and I. R. Niesman
PV1 Is a Key Structural Component for the Formation of the Stomatal and Fenestral Diaphragms
Mol. Biol. Cell, August 1, 2004; 15(8): 3615 - 3630.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. M. Kilani, K. A. Mohammed, N. Nasreen, J. A. Hardwick, M. H. Kaplan, R. S. Tepper, and V. B. Antony
Respiratory Syncytial Virus Causes Increased Bronchial Epithelial Permeability
Chest, July 1, 2004; 126(1): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Kanazawa, S. Nomura, and J. Yoshikawa
Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis
Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Kanazawa, T. Yoshikawa, K. Hirata, and J. Yoshikawa
Effects of Pranlukast Administration on Vascular Endothelial Growth Factor Levels in Asthmatic Patients
Chest, May 1, 2004; 125(5): 1700 - 1705.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg
Comparative Evaluation of FGF-2-, VEGF-A-, and VEGF-C-Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability
Circ. Res., March 19, 2004; 94(5): 664 - 670.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Beebe, J. P. Jani, E. Knauth, P. Goodwin, C. Higdon, A. M. Rossi, E. Emerson, M. Finkelstein, E. Floyd, S. Harriman, et al.
Pharmacological Characterization of CP-547,632, a Novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy
Cancer Res., November 1, 2003; 63(21): 7301 - 7309.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Eriksson, R. Cao, J. Roy, K. Tritsaris, C. Wahlestedt, S. Dissing, J. Thyberg, and Y. Cao
Small GTP-Binding Protein Rac Is an Essential Mediator of Vascular Endothelial Growth Factor-Induced Endothelial Fenestrations and Vascular Permeability
Circulation, March 25, 2003; 107(11): 1532 - 1538.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. M. Hastings, D. R. Licence, G. J. Burton, D. S. Charnock-Jones, and S. K. Smith
Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17{beta}-Estradiol in the Mouse Uterus
Endocrinology, January 1, 2003; 144(1): 326 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Sorensson, W. Fierlbeck, T. Heider, K. Schwarz, D. S. Park, P. Mundel, M. Lisanti, and B. J. Ballermann
Glomerular Endothelial Fenestrae In Vivo Are Not Formed from Caveolae
J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2639 - 2647.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H Kanazawa, K Hirata, and J Yoshikawa
Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients
Thorax, October 1, 2002; 57(10): 885 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. S. Goligorsky, H. Li, S. Brodsky, and J. Chen
Relationships between caveolae and eNOS: everything in proximity and the proximity of everything
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F1 - F10.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Zhou, R. Mazurchuk, and R. M. Straubinger
Antivasculature Effects of Doxorubicin-containing Liposomes in an Intracranial Rat Brain Tumor Model
Cancer Res., May 1, 2002; 62(9): 2561 - 2566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. M. MCDONALD
Angiogenesis and Remodeling of Airway Vasculature in Chronic Inflammation
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S39 - 45.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Ferrara
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1358 - C1366.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. M. Dvorak and D. Feng
The Vesiculo-Vacuolar Organelle (VVO): A New Endothelial Cell Permeability Organelle
J. Histochem. Cytochem., April 1, 2001; 49(4): 419 - 432.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
I. Zachary and G. Gliki
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
Cardiovasc Res, February 16, 2001; 49(3): 568 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. L. Kwan, A. D. Gomez, P. Baluk, H. Hashizume, and D. M. McDonald
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P
Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L286 - L297.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. S. Chang, E. di Tomaso, D. M. McDonald, R. Jones, R. K. Jain, and L. L. Munn
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
PNAS, December 19, 2000; 97(26): 14608 - 14613.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Liao, Y. Li, W. O’Connor, L. Zanetta, R. Bassi, A. Santiago, J. Overholser, A. Hooper, P. Mignatti, E. Dejana, et al.
Monoclonal Antibody to Vascular Endothelial-cadherin Is a Potent Inhibitor of Angiogenesis, Tumor Growth, and Metastasis
Cancer Res., December 1, 2000; 60(24): 6805 - 6810.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. G. Lee, H. J. Yoon, Z. Zhu, H. Link, Z. Wang, J. M. Gwaltney Jr., M. Landry, and J. A. Elias
Respiratory Syncytial Virus Stimulation of Vascular Endothelial Cell Growth Factor/Vascular Permeability Factor
Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 662 - 669.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Fischer, M. Wobben, J. Kleinstuck, D. Renz, and W. Schaper
Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C935 - C944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Saaristo, T. A. Partanen, J. Arola, L. Jussila, M. Hytonen, A. Makitie, S. Vento, A. Kaipainen, H. Malmberg, and K. Alitalo
Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal Tumors
Am. J. Pathol., July 1, 2000; 157(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. J. Kaner, J. V. Ladetto, R. Singh, N. Fukuda, M. A. Matthay, and R. G. Crystal
Lung Overexpression of the Vascular Endothelial Growth Factor Gene Induces Pulmonary Edema
Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 657 - 664.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
K. Miyamoto, S. Khosrof, S.-E. Bursell, Y. Moromizato, L. P. Aiello, Y. Ogura, and A. P. Adamis
Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)
Am. J. Pathol., May 1, 2000; 156(5): 1733 - 1739.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Hashizume, P. Baluk, S. Morikawa, J. W. McLean, G. Thurston, S. Roberge, R. K. Jain, and D. M. McDonald
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Am. J. Pathol., April 1, 2000; 156(4): 1363 - 1380.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
H.M.W. Verheul, K. Hoekman, A.S. Jorna, E.F. Smit, and H.M. Pinedo
Targeting Vascular Endothelial Growth Factor Blockade: Ascites and Pleural Effusion Formation
Oncologist, April 1, 2000; 5(90001): 45 - 50.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
E. L. Lund, L. Bastholm, and P. E. G. Kristjansen
Therapeutic Synergy of TNP-470 and Ionizing Radiation: Effects on Tumor Growth, Vessel Morphology, and Angiogenesis in Human Glioblastoma Multiforme Xenografts
Clin. Cancer Res., March 1, 2000; 6(3): 971 - 978.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. R. Wedge, D. J. Ogilvie, M. Dukes, J. Kendrew, J. O. Curwen, L. F. Hennequin, A. P. Thomas, E. S. E. Stokes, B. Curry, G. H. P. Richmond, et al.
ZD4190: An Orally Active Inhibitor of Vascular Endothelial Growth Factor Signaling with Broad-Spectrum Antitumor Efficacy
Cancer Res., February 1, 2000; 60(4): 970 - 975.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. Angelov, B. Salhia, L. Roncari, G. McMahon, and A. Guha
Inhibition of Angiogenesis by Blocking Activation of the Vascular Endothelial Growth Factor Receptor 2 Leads to Decreased Growth of Neurogenic Sarcomas
Cancer Res., November 1, 1999; 59(21): 5536 - 5541.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. W. Cohen, J. M. Carbajal, and R. C. Schaeffer Jr.
VEGF stimulates tyrosine phosphorylation of beta -catenin and small-pore endothelial barrier dysfunction
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2038 - H2049.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H. A. Weich, V. P. Torchilin, F. Yuan, and R. K. Jain
Augmentation of Transvascular Transport of Macromolecules and Nanoparticles in Tumors Using Vascular Endothelial Growth Factor
Cancer Res., August 1, 1999; 59(16): 4129 - 4135.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Grunstein, W. G. Roberts, O. Mathieu-Costello, D. Hanahan, and R. S. Johnson
Tumor-derived Expression of Vascular Endothelial Growth Factor Is a Critical Factor in Tumor Expansion and Vascular Function
Cancer Res., April 1, 1999; 59(7): 1592 - 1598.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Fischer, M. Clauss, M. Wiesnet, D. Renz, W. Schaper, and G. F. Karliczek
Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO
Am J Physiol Cell Physiol, April 1, 1999; 276(4): C812 - C820.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak
Vascular endothelial growth factor (VEGF) and its receptors
FASEB J, January 1, 1999; 13(1): 9 - 22.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
W. G. Roberts, J. Delaat, M. Nagane, S. Huang, W. K. Cavenee, and G. E. Palade
Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression
Am. J. Pathol., October 1, 1998; 153(4): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
PNAS, April 14, 1998; 95(8): 4607 - 4612.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. Esser, K. Wolburg, H. Wolburg, G. Breier, T. Kurzchalia, and W. Risau
Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro
J. Cell Biol., February 23, 1998; 140(4): 947 - 959.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Esser, M. Lampugnani, M Corada, E Dejana, and W Risau
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
J. Cell Sci., January 7, 1998; 111(13): 1853 - 1865.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Chen, F. Braet, S. Brodsky, T. Weinstein, V. Romanov, E. Noiri, and M. S. Goligorsky
VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells
Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1053 - C1063.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.